Home » Topics » Regulatory » Patents

Patents
RSS

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

CoCensys/Acea reveal new AMPA receptor antagonists/positive modulators

Dec. 3, 1997

Antiangina agents in development at Sankyo

Dec. 3, 1997

Water-soluble taxanes reported in patent literature

Dec. 3, 1997

Takeda discloses new series of prolactin secretion inhibitors

Dec. 3, 1997

Maillard reaction inhibitors from Kissei

Dec. 3, 1997

Dopamine receptor subtype-specific ligands prepared at Neurogen

Dec. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...